EndoGastric Solutions Advises A New Publication on TIF 2.0 in Therapeutic Advances in Gastroenterology
The article, authored by Glenn Ihde, MD, a board-certified general surgeon at the Matagorda Medical Group in Bay City, Texas, provides an overview of current best practices with respect to TIF 2.0 as a stand-alone procedure as well as in conjunction with hiatal hernia (HH) repair.
EndoGastric Solutions® Announces New Data Demonstrating pH Control Following TIF 2.0 and Hiatal Hernia Repair Procedures in GERD Patients
2/5/19: The TIF 2.0 procedure is a minimally invasive endoscopic intervention performed with the EsophyX® device that enables anatomic correction of the gastroesophageal valve without the resulting complications associated with traditional fundoplication. The retrospective data are reported in a paper titled “pH Scores in Hiatal Repair with Transoral Incisionless Fundoplication,” and appear in the January - March 2019 issue of the Journal of the Society of Laparoendoscopic Surgeons.
EndoGastric Solutions Announces New Data Demonstrating the Feasibility, Safety and Efficacy of EsophyX® Z Device in TIF 2.0 Procedure Following Peroral Endoscopic Myotomy
6/26/18: This study, titled, “Transoral Incisionless Fundoplication for reflux after peroral endoscopic myotomy: a crucial addition to our arsenal” appeared in the May issue of Endoscopy International Open.
EndoGastric® Solutions Announces Expanded Medicare Reimbursement for Transoral Incisionless Fundoplication (TIF®) Procedure
Medicare beneficiaries in 10 Midwestern and Northeastern states will soon have reimbursed access to the Transoral Incisionless Fundoplication (TIF®) procedure following a decision by Medicare Administrative Contractor (MAC) National Government Services, Inc. (NGS). Effective December 1, 2017,...
EndoGastric Solutions® Expands Commercial Leadership Team to Meet Increased Demand for TIF® Procedure for Reflux
EndoGastric Solutions Inc. (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced today the addition of two senior executives to its leadership team: Martin Reid, Vice President of Sales, and Ted Stephens, Vice...
EndoGastric Solutions to Host Product Theater Session on the TIF® Procedure at Digestive Disease Week® (DDW) 2017
EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced today that the company will host an educational session on the Transoral Incisionless Fundoplication (TIF®) procedure at Digestive Disease Week® (DDW) 2017,...